Member Info for larry10

https://twitter.com/NovacytGroup/status/1455867455365074946?t=nK5hqx9IOr15i4mwUXr0zA&s=19

I Can confirm what Kaeren says.

Hi Larry,



There is a webinar on the 11th but as far as I am aware David Allmond will not be making an appearance.



Kind regards,

-----
Thats thé answer i just got from Mandy

Merci Pierrick. Mais il a tord, DA ne devrait pas parler lors de ce webinar. Stoke, Cook et papenburg doivent parler.

Aaah yes gasman, i forgot this one.
Yes he must have talked about this.

So in the end it was just french nonsense, as Always on Boursorama (french board).
DA wont speak there. Mr. Papenburg, Mr Cook, and Mme Stoke are speaking there.

Indeed c123, i can't find this post about a webinar with DA.
Dont think it's true, we would have known by now, it would be in just 10 days.
So to take with a pinch of salt if we dont have a Real confirmation imho

Pierrick, je n'arrive pas à trouver ce post de logos. Tu peux copier le lien stp ?

Didnyou knew this same résolution passed last year too ? Have they use it ?

Better spent their money on direct sales development, buy a company, create a production Line in the US etc etc imho

Are you sure it will start ? ...

EA to C..

Exécutive assistant to ......... ?

Whats the C for please ?

You need to have a monthly read on it to know when it changes because dates are not often accurate.

Blk didnt sold this month for example.
JO Hambro has 950ks

Not sure novacyt often shoots about things...
They havent been shooting about co-prep, ImuPLEX, ResPLEX HiberPLEX etc. So does it mean theyre developping those for nothing ?

Not sure !

Drb83 :

https://twitter.com/Larry64450205/status/1453431014450139139?t=W2AUkGJCP93MCpntln22HA&s=19

Source below.

It is primer design ltd, inventors are two staff members from ncyt.

Not much réaction on social medias for this.
Im surprised because i find this very good. So, i try to bring attention with a New post.
Thanks to gggg for the original find of course.

https://twitter.com/Larry64450205/status/1453328036829466625?t=Y6w2b_OZZnbuH7Wlz8LQQQ&s=19

Advantages of the invention :

- New very sensitive method of SARS-CoV-2 detection
- No cross reactivity = No false positives
- Distinguish low viral loads from high viral loads ! = Determine level of infection

I like this part also :

"Therapeutic methods of the invention"

"The invention also provides a method of treating sars-cov-2 in a patient having a high viral load"

https://twitter.com/Larry64450205/status/1453328036829466625?t=-E_ULB45loUTRP33bk2p2g&s=19

That we can't now for sure 100% brokermanstan.
But when you see a 80k shares buy, there are no much pis that Can afford it imho.

On novacyt, for tr1, ii need to have 3%. Then déclare every % above so 4%. 5% etc. Cf aim admission rules on ncyt website

Blackrock is still here in fact.
Dunno why morningstar shows them as sold.
From my knowledge, they have 1.9m shares.
I know that from the wsj website in ownership, and confirmed through Bloomberg.

Im sure Duncan Can help you with that...lol !

Just read the explained egm resolutions written by the company,
And watch the investor meet company.

Youll have your answers. Serious ones.

How many posts subjects have you to write every day crl123 ?
Board is getting unreadable with your 10+ New subjects a day imho...

Utter deramping from Duncan as usual...